Medivation (MDVN) Again Rejects Sanofi's (SNY) 'Substantially Inadequate Proposal'
Tweet Send to a Friend
Medivation, Inc. (NASDAQ: MDVN) today reiterated its rejection of Sanofi's (NYSE: SNY) substantially inadequate proposal to acquire the Company for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE